Comparison of No-Test Telehealth and In-Person Medication Abortion.

ABSTRACT:

Importance

In the US, access to medication abortion using history-based (no-test) eligibility assessment, including through telehealth and mailing of mifepristone, has grown rapidly. Additional evidence on the effectiveness and safety of these models is needed.

Objective

To evaluate whether medication abortion with no-test eligibility assessment and mailing of medications is as effective as in-person care with ultrasonography and safe overall.

Design, setting, and participants

Prospective, observational study with noninferiority analysis. Sites included 4 abortion-providing organizations in Colorado, Illinois, Maryland, Minnesota, Virginia, and Washington from May 2021 to March 2023. Eligible patients were seeking medication abortion up to and including 70 days' gesta

SUBMITTER: Ralph LJ 

PROVIDER: S-EPMC11197442 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature